Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: A retrospective study

CardioVascular and Interventional Radiology

Volumn 35, Issue 5, 2012, Pages 1074-1082

  Haidu, Marion ^a   Dobrozemsky, Georg ^a   Schullian, Peter ^a   Widmann, Gerlig ^a   Klaus, Alexander ^a   Weiss, Helmut ^a   Margreiter, Raimund ^a   Bale, Reto ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cholangiocarcinoma; Radiofrequency ablation; Recurrence; Stereotaxy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT FISTULA; BILIOBRONCHUS FISTULA; BILOMA; BRONCHUS FISTULA; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE FREE SURVIVAL; FALSE ANEURYSM; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LUNG EMBOLISM; MALE; MEDICAL DEVICE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RETREATMENT; STEREOTACTIC RADIOFREQUENCY ABLATION; STEREOTACTIC TREATMENT; SURVIVAL RATE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84867572859     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0288-6     Document Type: Article

References (47)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366(9493):1303-1314
2. DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755-762
3. Endo I, Gonen M, Yopp AC et al (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248:84-96
4. Aljiffry M, Abdulelah A, Walsh M et al (2009) Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg 208:134-147
5. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308-321
6. McGahan JP, Browning PD, Brock JM et al (1990) Hepatic ablation using radiofrequency electrocautery. Invest Radiol 25:267-270
7. Rossi S, Fornari F, Pathies C et al (1990) Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 76:54-57
8. Lau WY, Lai EC (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20-25
9. Chiou YY, Hwang JI, Chou YH et al (2005) Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 21:304-309
10. Rai R, Manas D, Rose J (2005) Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantationa case report. World J Gastroenterol 11:612-613
11. Zgodzinski W, Espat NJ (2005) Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma. World J Gastroenterol 11:5239-5240
12. Slakey DP (2002) Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg 68:395-397
13. Carrafiello G, Lagana D, Cotta E et al (2010) Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol 33:835-839
14. Kim JH, Won HJ, Shin YM et al (2011) Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. Am J Roentgenol 196:W205-W209
15. Widmann G, Haidu M, Schullian P et al (2011) Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and inter-operator performance. Cardiovasc Intervent Radiol. doi: 10.1007/s00270-011-0200-4
16. Greene F, Page D, Fleming I et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
17. Bale R, Widmann G, Haidu M (2011) Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol 34:852-856
18. Bale R, Widmann G, Stoffner R (2010) Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol 75:32-36
19. Widmann G, Schullian P, Haidu M et al (2010) Respiratory motion control for stereotactic and robotic liver interventions. Int J Med Robot 6:343-349
20. Nevinny-Stickel M, Sweeney RA, Bale RJ et al (2004) Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vacuum technique. Strahlenther Onkol 180:117-122
21. Bale RJ, Vogele M, Rieger M et al (1999) A new vacuum device for extremity immobilization. AJR Am J Roentgenol 172:1093-1094
22. Smith KR, Frank KJ, Bucholz RD (1994) The NeuroStationa highly accurate, minimally invasive solution to frameless stereotactic neurosurgery. Comput Med Imaging Graph 18:247-256
23. Bale RJ, Laimer I, Martin A et al (2006) Frameless stereotactic cannulation of the foramen ovale for ablative treatment of trigeminal neuralgia. Neurosurgery 59(4 suppl 2):ONS394-ONS3401
24. Bucholz RD, Ho HW, Rubin JP (1993) Variables affecting the accuracy of stereotactic localization using computerized tomography. J Neurosurg 79:667-673
25. Seror O, N'Kontchou G, Ibraheem M et al (2008) Large HCCs: multipolar RF ablation with three internally cooled bipolar electrodesinitial experience in 26 patients. Radiology 248:288-296
26. Bruners P, Schmitz-Rode T, Gunther RW et al (2008) Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results. Rofo 180:216-222
27. Frericks BB, Ritz JP, Roggan A et al (2005) Multipolar radiofrequency ablation of hepatic tumors: initial experience. Radiology 237:1056-1062
28. Laeseke PF, Sampson LA, Haemmerich D et al (2006) Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 241:116-124
29. Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728-739
30. Poon RT, Ng KK, Lam CM et al (2004) Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 239:441-449
31. Ercolani G, Vetrone G, Grazi GL et al (2010) Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 252:107-114
32. Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633-1637
33. Madariaga JR, Iwatsuki S, Todo S et al (1998) Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227:70-79
34. de Groen PC, Gores GJ, LaRusso NF et al (1999) Biliary tract cancers. N Engl J Med 341:1368-1378
35. Anderson CD, Pinson CW, Berlin J et al (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9:43-57
36. Burger I, Hong K, Schulick R et al (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16:353-361
37. Kim JH, Yoon HK, Sung KB et al (2008) Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 113:1614-1622
38. Aliberti C, Benea G, Tilli M et al (2008) Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 31:883-888
39. Hammill CW, Wong LL (2008) Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am Coll Surg 207:594-603
40. Wang SC, Bester L, Burnes JP et al (2010) Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer. J Med Imaging Radiat Oncol 54:178-187
41. Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16(suppl 2):ii93-ii96
42. Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321-328
43. Mulier S, Ni Y, Jamart J et al (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158-171
44. Lu DS, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14:1267-1274
45. Curley SA, Marra P, Beaty K et al (2004) Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239:450-458
46. Mulier S, Mulier P, Ni Y et al (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206-1222
47. Cunningham SC, Choti MA, Bellavance EC et al (2007) Palliation of hepatic tumors. Surg Oncol 16:277-291